| 摘要 |
PCT No. PCT/FI93/00119 Sec. 371 Date Oct. 31, 1994 Sec. 102(e) Date Oct. 31, 1994 PCT Filed Mar. 25, 1993 PCT Pub. No. WO93/19746 PCT Pub. Date Oct. 14, 1993Transdermal preparations containing as active ingredient toremifene or one of its metabolites N-demethyltoremifene or 4-hydroxy-toremifene or their pharmaceutically acceptable non-toxic salts are useful for the treatment of cancers localized in the skin or on a short distance form the skin such as metastatic lesions of breast cancer. They may also be used in adjuvant therapy of breast cancer and in the reversal of multidrug resistance of cancer cells to cytotoxic drugs. Such transdernal preparations are of particular interest in the treatment of melanoma, lymphoma, Kaposi's sarcoma and fungoides mycosis. |
